Sellas Life Sciences Group Inc reports results for the quarter ended in June - Earnings Summary

Sellas Life Sciences

10/08/2023 22:43

* Sellas Life Sciences Group Inc  SLS.OQ  reported a
quarterly
adjusted loss of 31 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 35 cents per share.
    * Reported revenue was zero​; analysts expected $3.25
million. 
    * Sellas Life Sciences Group Inc's reported EPS for the
quarter
was a loss of 31 cents​.
    * The mean earnings estimate of analysts had fallen by
about 634.5% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Sellas Life Sciences Group Inc shares had held steady so
far
this quarter and lost 33.5% so far this year.
    * The company reported a quarterly loss of $8.84 million.
    * Wall Street's median 12-month price target for Sellas Life
Sciences Group Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 09:42 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.35          -0.31          Beat
 Mar. 31 2023      -0.29          -0.47          Missed
 Dec. 31 2022      -0.32          -0.43          Missed
 Sep. 30 2022      -0.39          -0.34          Beat